MedPath

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Not Applicable
Recruiting
Conditions
Bladder Cancer
Interventions
Procedure: En-Bloc Resection of Bladder Tumours
Registration Number
NCT06281080
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Age between 18 and 75 years
  2. Body mass index <35 kg/m2
  3. Bladder tumour located <3 cm in size; clinically non-muscle invasive bladder tumour
  4. Clinically indicated for en-bloc resection.
  5. Willingness to participate as demonstrated by giving informed consent
Exclusion Criteria
  1. Presence of endoscopic or imaging signs of detrusor muscle invasion
  2. Contraindication to general anaesthesia / spinal anaesthesia
  3. ASA > 2 patients
  4. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  5. Untreated active infection
  6. Un-corrected coagulopathy
  7. Presence of another malignancy or distant metastasis
  8. Emergency surgery
  9. Vulnerable population (e.g. mentally disabled, pregnant)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment armEn-Bloc Resection of Bladder TumoursPatients underwent En-Bloc Resection of Bladder Tumours using Agilis Robotic System.
Primary Outcome Measures
NameTimeMethod
Successful en-bloc tumour resection by the robotic systemDuring the operation

The number of cases completed the intervention by robotic system

Secondary Outcome Measures
NameTimeMethod
Need of bladder irrigationWithin 30 days after the study intervention.

Number of subject

Intra-operative bladder perforation eventDuring operation

Number of subject

Residual tumour or upstaging of tumour after second look TURBTWithin 30 days after the study intervention.

Number of subject

Post-operative complicationsWithin 90 days after the study intervention

Complication is defined according to the Clavien-Dindo Classification

Dissection time and speedDuring operation

Time required for submucosal dissection from the first cut

Total procedure timeDuring operation

Time from insertion of the robotic system into urethra until removal of the specimen from the body

Surgeon Console timeDuring operation

From the time start of any procedure to completion of urethral catheter insertion

Presence of detrusor muscle in specimenDuring operation

Presence of detrusor muscle in specimen

Resection MarginDuring operation

Number of subject with Negative resection margin

Trial Locations

Locations (1)

Prince of Wales Hospital

🇭🇰

Sha Tin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath